[{"orgOrder":0,"company":"Huazhong University of Science and Technology","sponsor":"Wuhan Wuchang Hospital | Abinopharm Inc","pharmaFlowCategory":"DU","therapeuticArea":"Sleep","country":"CHINA","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Urolithin A","moa":"Undisclosed","graph1":"Sleep","graph2":"Undisclosed","graph3":"Huazhong University of Science and Technology","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Sleep","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Huazhong University of Science and Technology \/ Wuhan Wuchang Hospital | Abinopharm Inc","highestDevelopmentStatusID":"1","companyTruncated":"Huazhong University of Science and Technology \/ Wuhan Wuchang Hospital | Abinopharm Inc"},{"orgOrder":0,"company":"Amazentis","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"SWITZERLAND","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Urolithin A","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Amazentis","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Amazentis \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Amazentis \/ Undisclosed"},{"orgOrder":0,"company":"Amazentis","sponsor":"Goethe University","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"SWITZERLAND","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Urolithin A","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase I","graph3":"Amazentis","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Amazentis \/ Goethe University","highestDevelopmentStatusID":"6","companyTruncated":"Amazentis \/ Goethe University"},{"orgOrder":0,"company":"Amazentis","sponsor":"Mprex Healthcare Pvt. Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"SWITZERLAND","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Urolithin A","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Amazentis","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Amazentis \/ Mprex Healthcare Pvt. Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Amazentis \/ Mprex Healthcare Pvt. Ltd."},{"orgOrder":0,"company":"Amazentis","sponsor":"Universit\u00e9 du Qu\u00e9bec a Montr\u00e9al | McGill University Health Centre Research Institute","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"SWITZERLAND","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Urolithin A","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Amazentis","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Amazentis \/ Universit\u00e9 du Qu\u00e9bec a Montr\u00e9al | McGill University Health Centre Research Institute","highestDevelopmentStatusID":"1","companyTruncated":"Amazentis \/ Universit\u00e9 du Qu\u00e9bec a Montr\u00e9al | McGill University Health Centre Research Institute"},{"orgOrder":0,"company":"Amazentis","sponsor":"Mprex Healthcare Pvt. Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"SWITZERLAND","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Urolithin A","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Amazentis","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Amazentis \/ Mprex Healthcare Pvt. Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Amazentis \/ Mprex Healthcare Pvt. Ltd."},{"orgOrder":0,"company":"Amazentis","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"SWITZERLAND","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Urolithin A","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Approved FDF","graph3":"Amazentis","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Amazentis \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Amazentis \/ Undisclosed"},{"orgOrder":0,"company":"Amazentis","sponsor":"Scripps Research","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"SWITZERLAND","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Urolithin A","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Preclinical","graph3":"Amazentis","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Amazentis \/ Scripps Research","highestDevelopmentStatusID":"4","companyTruncated":"Amazentis \/ Scripps Research"},{"orgOrder":0,"company":"McGill University Health Centre Research Institute","sponsor":"Amazentis","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"CANADA","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Urolithin A","moa":"Undisclosed","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Phase II","graph3":"McGill University Health Centre Research Institute","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"McGill University Health Centre Research Institute \/ Amazentis","highestDevelopmentStatusID":"8","companyTruncated":"McGill University Health Centre Research Institute \/ Amazentis"}]

Find Clinical Drug Pipeline Developments & Deals for Urolithin A

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Huazhong University of Science and Technology

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Huazhong University of Science and Technology

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Details : Urolithin A is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Sleep Wake Disorders.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          May 25, 2025

                          Lead Product(s) : Urolithin A

                          Therapeutic Area : Sleep

                          Highest Development Status : Undisclosed

                          Sponsor : Wuhan Wuchang Hospital | Abinopharm Inc

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          PackExpo
                          Not Confirmed
                          PackExpo
                          Not Confirmed

                          Details : Urolithin A is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          February 28, 2025

                          Lead Product(s) : Urolithin A

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Mprex Healthcare Pvt. Ltd.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          PackExpo
                          Not Confirmed
                          PackExpo
                          Not Confirmed

                          Lead Product(s) : Urolithin A

                          Therapeutic Area : Musculoskeletal

                          Study Phase : Undisclosed

                          Sponsor : Université du Québec a Montréal | McGill University Health Centre Research Institute

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Urolithin A is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Frailty.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          August 16, 2024

                          Lead Product(s) : Urolithin A

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Undisclosed

                          Sponsor : Université du Québec a Montréal | McGill University Health Centre Research Institute

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          PackExpo
                          Not Confirmed
                          PackExpo
                          Not Confirmed

                          Details : Urolithin A is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          April 12, 2024

                          Lead Product(s) : Urolithin A

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Mprex Healthcare Pvt. Ltd.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          McGill University Health Centre Research Institute

                          Country arrow
                          PackExpo
                          Not Confirmed

                          McGill University Health Centre Research Institute

                          Country arrow
                          PackExpo
                          Not Confirmed

                          Details : Mitopure (Urolithin A) is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.

                          Product Name : Mitopure

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          March 21, 2024

                          Lead Product(s) : Urolithin A

                          Therapeutic Area : Pulmonary/Respiratory Diseases

                          Highest Development Status : Phase II

                          Sponsor : Amazentis

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          PackExpo
                          Not Confirmed
                          PackExpo
                          Not Confirmed

                          Details : Mitopure (Urolithin A) is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Aging.

                          Product Name : Mitopure

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          February 21, 2023

                          Lead Product(s) : Urolithin A

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Undisclosed

                          Sponsor : Goethe University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          PackExpo
                          Not Confirmed
                          PackExpo
                          Not Confirmed

                          Details : Mitopure® is a highly pure form of Urolithin A; a bioactive dietary metabolite that is produced by gut bacteria after eating certain foods, such as the pomegranate, though it is difficult for most people to get enough of this specialized nutrient from f...

                          Product Name : Mitopure

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          July 07, 2022

                          Lead Product(s) : Urolithin A

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Preclinical

                          Sponsor : Scripps Research

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          PackExpo
                          Not Confirmed
                          PackExpo
                          Not Confirmed

                          Details : New research by scientists in Switzerland shows supplementation with Mitopure (Urolithin A) had exercise-like effects on muscle strength after 4-months (+12%), published in Cell Reports Medicine.

                          Product Name : Mitopure

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          May 17, 2022

                          Lead Product(s) : Urolithin A

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Approved FDF

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          PackExpo
                          Not Confirmed
                          PackExpo
                          Not Confirmed

                          Details : Urolithin A is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          August 02, 2021

                          Lead Product(s) : Urolithin A

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          PackExpo
                          Not Confirmed
                          PackExpo
                          Not Confirmed

                          Details : Urolithin A is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          November 13, 2019

                          Lead Product(s) : Urolithin A

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Atlantia Food Clinical Trials

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank